Crosslinking effect of Nordihydroguaiaretic acid (NDGA) on decellularized heart valve scaffold for tissue engineering.
Decellularized heart valve scaffolds possess many desirable properties in valvular tissue engineering. However, their current applications were limited by short durability, easily structural dysfunction and immunological competence. Although crosslinking with chemical reagents, such as glutaraldehyde (GA), will enhance the mechanical properties, the low long-term stability and cytotoxicity of the scaffolds remains potential problem. Nordihydroguaiaretic acid (NDGA) is a bioactive natural product which is able to crosslink collagen and was proven to be effective in preparation of scaffold for tendon tissue engineering. In this paper, NDGA crosslinked decellularized heart valve scaffolds demonstrated higher tensile strength, enzymatic hydrolysis resistance and store stability than the non-crosslinked ones. Its mechanical properties and cytocompability were superior to that of GA-crosslinked heart valve matrix. Below the concentration of 10 microg/ml, NDGA has no visible cytotoxic effect on both endothelial cells (EC) and valvular interstitial cells (VIC) and its cytotoxicity is much less than that of GA. The LC50 (50% lethal concentration) of NDGA on ECs and VICs are 32.6 microg/ml and 47.5 microg/ml, respectively, while those of GA are almost 30 times higher than NDGA (P < 0.05). ECs can attach to and maintain normal morphology on the surface of NDGA-crosslinked valvular scaffolds but not GA-crosslinked ones. This study demonstrated that NDGA-crosslinking of decellularized valvular matrix is a promising approach for preparation of heart valve tissue engineering scaffolds.
Lü
Xiqin
X
School of Life Science, East China Normal University, 3663 Zhongshanbei Road, Shanghai, 200062, People's Republic of China.
Zhai
Wanyin
W
Zhou
Yanling
Y
Zhou
Yue
Y
Zhang
Hongfeng
H
Chang
Jiang
J
D000818:Animals; D001021:Aortic Valve / Q000737:chemistry*; D001705:Bioprosthesis; D002474:Cell-Free System; D002478:Cells, Cultured; D003432:Cross-Linking Reagents / Q000737:chemistry; D042783:Endothelial Cells / Q000166:cytology / Q000502:physiology*; D006350:Heart Valve Prosthesis; D009637:Masoprocol / Q000737:chemistry*; D008422:Materials Testing; D011474:Prosthesis Design; D013552:Swine; D023822:Tissue Engineering / Q000295:instrumentation*; D054457:Tissue Scaffolds
D003432:Cross-Linking Reagents; D009637:Masoprocol